People taking popular new weight-loss drugs such as Wegovy and Zepbound often celebrate the number of pounds they shed and ...

Scientists look to genetics to explain why GLP-1 drugs work for some people but not for others People taking popular new ...

An analysis found that a shrinking waist size was responsible for only around a third of the cardiovascular benefits in ...

The current chairman of the Novo Nordisk Foundation, Lars Rebien Sorensen, who served as the pharma's chief executive from ...

Novo Nordisk (NVO) recruits top healthcare analyst Michael Novod, a long time bull of the company, as head of its investor ...

This article was reviewed by Darragh O’Carroll, MD. Long-Term Side Effects of Wegovy® Key takeaways: The long-term side ...

Novo Nordisk today announced plans to present 11 abstracts at the 76th Annual American Association for the Study of Liver ...

It might sound shocking to read about such drastic actions, but it’s stories of overweight children being bullied and too ...

This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives ...

According to the Gallup National Health and Well-Being Index, America’s adult obesity rate has fallen to 37% in 2025, down ...

Novo Nordisk's Q3 results hinge on Ozempic and Wegovy sales as demand growth slows amid rivalry, market limits and compounded ...

Karen McGonigal's three daughters say she became "desperate" to lose weight after a long-term relationship ended - with ...